-transparent.png){kind=logo}
The effect of BN 52021, a selective platelet activating factor (PAF) antagonist was studied on dithranol-induced irritant dermatitis. Pretreatment of the skin with 0.45% BN 52021 ointment significantly suppressed the decrease in capillary resistance, rise in skin temperature and increase in skin-fold thickness produced by dithranol.
Related Publications
L Kemény, and
M Csató, and
P Braquet, and
A Dobozy
May 1988,
Prostaglandins,
L Kemény, and
M Csató, and
P Braquet, and
A Dobozy
April 1988,
The British journal of dermatology,
L Kemény, and
M Csató, and
P Braquet, and
A Dobozy
January 1987,
Advances in experimental medicine and biology,
L Kemény, and
M Csató, and
P Braquet, and
A Dobozy
January 1989,
Pharmacological research,
L Kemény, and
M Csató, and
P Braquet, and
A Dobozy
January 1989,
International archives of allergy and applied immunology,
L Kemény, and
M Csató, and
P Braquet, and
A Dobozy
January 1992,
Prostaglandins, leukotrienes, and essential fatty acids,
L Kemény, and
M Csató, and
P Braquet, and
A Dobozy
January 1991,
International journal of pancreatology : official journal of the International Association of Pancreatology,
L Kemény, and
M Csató, and
P Braquet, and
A Dobozy
December 1995,
Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie,
L Kemény, and
M Csató, and
P Braquet, and
A Dobozy
July 1989,
Immunology,
L Kemény, and
M Csató, and
P Braquet, and
A Dobozy
July 1986,
Transplantation,
